363 related articles for article (PubMed ID: 36474082)
1. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
[TBL] [Abstract][Full Text] [Related]
2. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
[TBL] [Abstract][Full Text] [Related]
3. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice.
Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY
Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280
[TBL] [Abstract][Full Text] [Related]
4. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro.
Yan C; Yang S; Shao S; Zu R; Lu H; Chen Y; Zhou Y; Ying X; Xiang S; Zhang P; Li Z; Yuan Y; Zhang Z; Wang P; Xie Z; Wang W; Ma H; Sun Y
J Ethnopharmacol; 2024 May; 326():117915. PubMed ID: 38360383
[TBL] [Abstract][Full Text] [Related]
5. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway.
Shan X; Lv S; Huang P; Zhang W; Jin C; Liu Y; Li Y; Jia Y; Chu X; Peng C; Zhang C
Mol Neurobiol; 2024 Apr; 61(4):2297-2312. PubMed ID: 37874481
[TBL] [Abstract][Full Text] [Related]
6. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
7. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.
Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S
Front Pharmacol; 2020; 11():381. PubMed ID: 32317964
[TBL] [Abstract][Full Text] [Related]
8. [Network pharmacology-based study of the therapeutic mechanism of resveratrol for Alzheimer's disease].
Fang Y; Su Z; Si W; Liu Y; Li J; Zeng P
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):10-19. PubMed ID: 33509748
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology analysis and experimental validation of
Li D; Hu Y; Liu X; Yu G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):84-97. PubMed ID: 38105702
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the therapeutic mechanism of Hengqing II decoction in Alzheimer's disease using network pharmacology and molecular docking techniques.
Wang Y; Jiang J; Chen S; Chen Q; Yan X; Shen X
Fitoterapia; 2024 Apr; 174():105860. PubMed ID: 38367649
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
[TBL] [Abstract][Full Text] [Related]
14. Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway.
Guo S; Wang J; Xu H; Rong W; Gao C; Yuan Z; Xie F; Bi K; Zhang Z; Li Q
Oxid Med Cell Longev; 2019; 2019():9096409. PubMed ID: 31354916
[TBL] [Abstract][Full Text] [Related]
15. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice.
Xu YM; Lu FM; Xu HC; Zhang J; Hei SY; Qiu YH; Cai YF; Zhang SJ; Zhao M
Rejuvenation Res; 2023 Jun; 26(3):105-115. PubMed ID: 37073462
[TBL] [Abstract][Full Text] [Related]
16. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
[TBL] [Abstract][Full Text] [Related]
17. Role of corn silk for the treatment of Alzheimer's disease: A mechanism research based on network pharmacology combined with molecular docking and experimental validation.
Tao TZ; Wang L; Liu J
Chem Biol Drug Des; 2023 Nov; 102(5):1231-1247. PubMed ID: 37563784
[TBL] [Abstract][Full Text] [Related]
18. A Network Pharmacology-Based Study on the Mechanism of Dibutyl Phthalate of
Simayi J; Bayinsang ; Nuermaimaiti M; Hailati S; Han M; Reheman Z; Wumaier A; Zhou W
Biomed Res Int; 2022; 2022():9494548. PubMed ID: 36593772
[TBL] [Abstract][Full Text] [Related]
19. Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer's disease by network pharmacology and molecular docking.
Cheung S; Zhong Y; Wu L; Jia X; He MQ; Ai Y; Jiao Q; Liang Q
J Ethnopharmacol; 2024 Jun; 328():117976. PubMed ID: 38492794
[TBL] [Abstract][Full Text] [Related]
20. Exploring Acori Tatarinowii Rhizoma and Polygalae Radix in Alzheimer's: Network pharmacology and molecular docking analysis.
Tong T; Cheng B; Tie S; Ouyang D; Cao J
Medicine (Baltimore); 2024 Apr; 103(15):e37740. PubMed ID: 38608086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
